Ryo Okubo, PhD, MD
Department of Clinical Epidemiology, Translational Medical Center, National Center of Neurology and Psychiatry, Tokyo, Japan; Corresponding author: Ryo Okubo, PhD, MD, Department of Clinical Epidemiology, Translational Medical Center, National Center of Neurology and Psychiatry, 4-1-1 Ogawa-Higashi, Kodaira, Tokyo 187-8551 ([email protected]).
Original Research
Differences Among Second-Generation Antipsychotics in Effects on HbA1c
March 30, 2022
The antipsychotic blonanserin was associated with less change in glycated hemoglobin (HbA1c) levels than olanzapine, and changes in BMI were lower for both blonanserin and aripiprazole. Study results indicate...
